AAN 2024 | Establishing the North American Prodromal Synucleinopathy (NAPS) Consortium
Aleksandar Videnovic, MD, Massachusetts General Hospital, Harvard Medical School, Boston, MA, talks on the establishment of the North American Prodromal Synucleinopathy (NAPS) Consortium.
What is Frontotemporal Dementia?
As the name suggests, Frontotemporal dementia (FTD) affects the frontal lobe and/or temporal lobes of the brain. Signs and symptoms vary, depending on which part of the brain is atrophying, or shrinking. Genetic mutations and dysfunctional proteins in the brain have been linked to FTD.
A Neurological Disease Paradigm Shift
In a paper published in The Lancet Neurology, a group of scientists, including NAPS Co-Investigator, Ronald Postuma, MD, MSc (McGill), argue that developing effective treatments for Parkinson’s disease demands a new way of classifying the disease for research purposes, one based not on clinical diagnosis but biology. The authors have called their biological model “SynNeurGe”.
Insights Into Prodromal Parkinson's and REM Sleep Behavior Disorder
Indu Subramanian (UCLA) speaks with REM Sleep Behavior Disorder (RBD) expert and NAPS Co-Investigator, Ronald Postuma, MD, MSc (McGill), about prodromal Parkinsons's disease and it's link to RBD.
Research Reveals Crucial Role of Saturated Fatty Acids in Memory Creation Process
Researchers uncover how brain fats are crucial for memory, identifying genes that could lead to treatments for Alzheimer's. This new understanding of fatty acids opens exciting avenues for neurodegenerative disease therapies.
RBD Quote of the Week: Aleksandar Videnovic, MD, MSc | Massachusetts General Hospital
“By focusing on RBD research, we have an unprecedented opportunity to develop clinical trials aimed at stopping the progression of neurodegenerative disorders, such as Parkinson’s, dementia with Lewy bodies, and multiple system atrophy. I can’t think of more rewarding work.”
– Aleksandar Videnovic, MD, MSc
Massachusetts General Hospital
Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies
Many studies have posed a-synuclein as a potential diagnostic and prognostic biomarker for Parkinson's Disease. Due to its abundance in the body, several modes for sample collection are currently being investigated, including tissue and fluid samples.
Installation of Yo-El Ju, MD as the Barbara Burton and Reuben M. Morriss III Professor at Washington University School of Medicine in St. Louis
The professorship was created through a bequest from the late Reuben M. Morriss III and Barbara Burton Morriss to Washington University, to advance Alzheimer’s disease research.
NAPS Consortium Site Spotlight: Emory University
Our team is committed to further the NAPS study's mission to support clinical care, advance discovery, promote education, and engage our community in order to improve the quality of life and care of individuals living with RBD. Learn more about the team at Emory University.
2nd Annual Center on Biological Rhythms and Sleep Symposium
The 2nd Annual Center on Biological Rhythms and Sleep Symposium was held at the Washington University School of Medicine in St. Louis in May 2023.
NAPS Consortium Site Spotlight: OHSU + VA Portland Health Care System (VAPORHCS)
Our team is committed to further the NAPS study's mission to support clinical care, advance discovery, promote education, and engage our community in order to improve the quality of life and care of individuals living with RBD. Learn more about the team at OHSU and VA Portland Health Care System (VAPORHCS).
NAPS Consortium Site Spotlight: UCLA
Our team is committed to further the NAPS study's mission to support clinical care, advance discovery, promote education, and engage our community in order to improve the quality of life and care of individuals living with RBD. Learn more about the team at UCLA.
NAPS Consortium Site Spotlight: University of Minnesota
Our team is committed to further the NAPS study's mission to support clinical care, advance discovery, promote education, and engage our community in order to improve the quality of life and care of individuals living with RBD. Learn more about the team at The University of Minnesota.
NAPS Consortium Site Spotlight: McGill University Health Centre Research Institute
Our team is committed to further the NAPS study's mission to support clinical care, advance discovery, promote education, and engage our community in order to improve the quality of life and care of individuals living with RBD. Learn more about the team at McGill University Health Centre Research Institute.
NAPS Consortium Site Spotlight: Washington University
Our team is committed to further the NAPS study's mission to support clinical care, advance discovery, promote education, and engage our community in order to improve the quality of life and care of individuals living with RBD. Learn more about the team at Washington University.
'I Have REM Sleep Behavior Disorder, Which Causes Me To Sleepwalk Myself Into Scary Situations'
By Camille Falconnier For Women’s Health Magazine